Recent findings from several labs, including ours, have implicated important non-apoptotic functions for the canonical apoptotic regulatory pathway in C. elegans. We have recently reported a miRISC enhancer screen that identified 126 genetic interactors. We further carried out extensive analyses of one of them, the CED-3 caspase previously known for its essential role in apoptosis (Weaver, et al. 2014). Our results indicated that a non-apoptotic caspase activity of CED-3 negatively regulates the expression of LIN-28 and likely also LIN-14 and DISL-2 (ribonuclease) in the LIN-28 pluripotency pathway in late larval development to support proper cell fate patterning. Following these findings, we have carried out two sets of experiments to address two important questions related to this non-apoptotic function of CED-3. First, we examined whether CED-3 cleavage renders the target protein more susceptible to other proteolysis pathways. Our data show that compromising the N-end rule ubiquitin (NRU) pathway delays the downregulation of LIN-28 protein and enhances the miRISC developmental timing defect including the appearance of supernumerary seam cells by early adulthood similar to our findings for CED-3 and miRISC. However, compromising the NRU pathway does not enhance
ced-3(lf) phenotypes, suggesting that the NRU pathway may act with CED-3 cleavage to repress the expression of LIN-28 and possibly other factors in the heterochronic pathway. Second, to systematically investigate the extent of non-apoptotic functions for the CED-3 caspase beyond temporal cell fate patterning, we have performed a
ced-3(lf) enhancer screen using a genome-wide RNAi approach. We identified over 500 candidate genes in the primary screen and confirmed more than 100 of these in a secondary screen. In combination with
ced-3(lf), RNAi of the candidate genes resulted in pleiotropic developmental defects. These genes encode proteins of diverse functional categories including protein stability regulators, signal transduction factors, RNA-binding proteins and transcriptional regulators, thus revealing the involvement of CED-3 caspase in a wide-range of non-apoptotic developmental regulatory pathways. Additional network and pathway analyses have implicated several proteins that are potential common targets of CED-3 and specific regulators identified in the above
ced-3(lf) enhancer screen. CED-3 cleavage assays, expression analyses and genetic analyses are being performed to characterize the interaction network and its functional significance. Altogether, our data suggest that the CED-3 caspase is widely used in non-apoptotic cellular processes to enhance the robustness of dynamic gene expression patterns of diverse regulatory pathways.